IS8277A - Blanda af serótónín endurupptöku hindra og glysínflutningsprótín gerð I hindra við meðferð á þunglyndi - Google Patents
Blanda af serótónín endurupptöku hindra og glysínflutningsprótín gerð I hindra við meðferð á þunglyndiInfo
- Publication number
- IS8277A IS8277A IS8277A IS8277A IS8277A IS 8277 A IS8277 A IS 8277A IS 8277 A IS8277 A IS 8277A IS 8277 A IS8277 A IS 8277A IS 8277 A IS8277 A IS 8277A
- Authority
- IS
- Iceland
- Prior art keywords
- inhibitor
- depression
- mixture
- treatment
- serotonin reuptake
- Prior art date
Links
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 title 2
- 102000014914 Carrier Proteins Human genes 0.000 title 1
- 108010078791 Carrier Proteins Proteins 0.000 title 1
- 208000020401 Depressive disease Diseases 0.000 title 1
- 239000004471 Glycine Substances 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 229940126570 serotonin reuptake inhibitor Drugs 0.000 title 1
- 239000003772 serotonin uptake inhibitor Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Addiction (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Nutrition Science (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49673803P | 2003-08-21 | 2003-08-21 | |
| DKPA200301198 | 2003-08-21 | ||
| PCT/DK2004/000547 WO2005018676A1 (en) | 2003-08-21 | 2004-08-18 | The combination of a serotonin reuptake inhibitor and a glycine transporter type 1 inhibitor for the treatment of depression |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS8277A true IS8277A (is) | 2006-01-31 |
Family
ID=34219531
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS8277A IS8277A (is) | 2003-08-21 | 2006-01-31 | Blanda af serótónín endurupptöku hindra og glysínflutningsprótín gerð I hindra við meðferð á þunglyndi |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20060223857A1 (https=) |
| EP (1) | EP1660130A1 (https=) |
| JP (1) | JP2007502785A (https=) |
| KR (1) | KR20060066729A (https=) |
| CN (1) | CN1867358A (https=) |
| AU (1) | AU2004266057A1 (https=) |
| BR (1) | BRPI0413587A (https=) |
| CA (1) | CA2536275A1 (https=) |
| IS (1) | IS8277A (https=) |
| MX (1) | MXPA06002002A (https=) |
| NO (1) | NO20061167L (https=) |
| WO (1) | WO2005018676A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003053942A1 (en) * | 2001-12-20 | 2003-07-03 | H. Lundbeck A/S | Aryloxyphenyl and arylsulfanylphenyl derivatives |
| WO2008100727A2 (en) * | 2007-02-14 | 2008-08-21 | The Trustees Of Columbia University In The City Of New York | High-dose glycine as a treatment for obsessive-compulsive disorder and obsessive-compulsive spectrum disorders |
| CN101338337B (zh) * | 2007-07-04 | 2011-11-02 | 北京华安佛医药研究中心有限公司 | 多态性位点基因型预测抑郁症及药效的用途、方法和试剂盒 |
| EP2380595A1 (en) | 2010-04-19 | 2011-10-26 | Nlife Therapeutics S.L. | Compositions and methods for selective delivery of oligonucleotide molecules to specific neuron types |
| CN102949364A (zh) * | 2011-08-30 | 2013-03-06 | 天津药物研究院 | 一种含有效成分盐酸维拉佐酮的缓释片 |
| US20210393621A1 (en) | 2018-10-26 | 2021-12-23 | The Research Foundation For The State University Of New York | Combination serotonin specific reuptake inhibitor and serotonin 1a receptor partial agonist for reducing l-dopa-induced dyskinesia |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6361957B1 (en) * | 1999-08-03 | 2002-03-26 | Glytech, Inc. | Assay for D-serine transport antagonist and use for treating psychosis |
| PT871440E (pt) * | 1995-12-07 | 2006-07-31 | Daniel C Javitt | Tratamento de sintomas negativos e cognitivos de esquizofrenia com antagonistas da captacao de glicina |
| NZ332780A (en) * | 1996-05-31 | 2000-07-28 | Allelix Neuroscience Inc | Substituted amines for the treatment of neurological and neuropsychiatric disorders |
| US6117855A (en) * | 1996-10-07 | 2000-09-12 | Merck Sharp & Dohme Ltd. | Use of a NK-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent |
| GB2336534A (en) * | 1998-04-24 | 1999-10-27 | Alec James Coppen | Anti-depressant - Folic Acid Combination |
| DOP2001000189A (es) * | 2000-06-30 | 2002-03-30 | Pfizer Prod Inc | Benzofenonas y sulfonas como inhibidores de la captación de glicina |
| WO2002008216A1 (en) * | 2000-07-21 | 2002-01-31 | H. Lundbeck A/S | Novel compounds and their use as glycine transport inhibitors |
| WO2003053942A1 (en) * | 2001-12-20 | 2003-07-03 | H. Lundbeck A/S | Aryloxyphenyl and arylsulfanylphenyl derivatives |
| WO2004000326A1 (en) * | 2002-06-20 | 2003-12-31 | H. Lundbeck A/S | Combination therapy wherein a serotonin reuptake inhibitor is used |
| EP2260844A1 (en) * | 2003-05-27 | 2010-12-15 | Merz Pharma GmbH & Co. KGaA | Combination of an NMDA Receptor Antagonist and a Selective Serotonin Reuptake Inhibitor for the Treatment of Depression and other Mood Disorders |
-
2004
- 2004-08-18 AU AU2004266057A patent/AU2004266057A1/en not_active Abandoned
- 2004-08-18 BR BRPI0413587-3A patent/BRPI0413587A/pt not_active IP Right Cessation
- 2004-08-18 MX MXPA06002002A patent/MXPA06002002A/es not_active Application Discontinuation
- 2004-08-18 KR KR1020067003210A patent/KR20060066729A/ko not_active Withdrawn
- 2004-08-18 WO PCT/DK2004/000547 patent/WO2005018676A1/en not_active Ceased
- 2004-08-18 EP EP04739042A patent/EP1660130A1/en not_active Withdrawn
- 2004-08-18 JP JP2006523530A patent/JP2007502785A/ja not_active Withdrawn
- 2004-08-18 CA CA002536275A patent/CA2536275A1/en not_active Abandoned
- 2004-08-18 US US10/568,133 patent/US20060223857A1/en not_active Abandoned
- 2004-08-18 CN CNA2004800304533A patent/CN1867358A/zh active Pending
-
2006
- 2006-01-31 IS IS8277A patent/IS8277A/is unknown
- 2006-03-13 NO NO20061167A patent/NO20061167L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2004266057A1 (en) | 2005-03-03 |
| CN1867358A (zh) | 2006-11-22 |
| EP1660130A1 (en) | 2006-05-31 |
| CA2536275A1 (en) | 2005-03-03 |
| MXPA06002002A (es) | 2006-05-17 |
| WO2005018676A1 (en) | 2005-03-03 |
| NO20061167L (no) | 2006-03-13 |
| BRPI0413587A (pt) | 2006-10-17 |
| KR20060066729A (ko) | 2006-06-16 |
| US20060223857A1 (en) | 2006-10-05 |
| JP2007502785A (ja) | 2007-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20043564L (no) | Follistatindomene som inneholder proteiner | |
| DK1495128T3 (da) | Forstærket proteinekspression i Bacillus | |
| EP1636250A4 (en) | SELF-ORGANIZING PEPTIDES CONTAINING MODIFICATIONS AND METHOD FOR THEIR USE | |
| DK1711207T3 (da) | Interferon-alpha-antistoffer og anvendelse heraf | |
| IL228034A0 (en) | Formulations with a high concentration of antibodies and proteins | |
| IL171109A (en) | Glycopegylation methods and proteins/peptides produced by the methods | |
| NO20055306D0 (no) | GITR ligand og GITR ligand relaterte molekyler og antistoffer og anvendelse derav | |
| EP1732581A4 (en) | POLYPEPTIDE TRANSDUCTION AND FUSOGENIC PEPTIDES | |
| DK1268431T3 (da) | 3-Cyanoquinoliner, 3-cyano-1,6-naphthyridiner og 3-cyano-1,7-naphthyridiner som proteinkinaseinhibitorer | |
| EP1701725A4 (en) | PROCESS AND COMPOSITIONS | |
| DK1663291T3 (da) | Rekombinante lubricinmolekyler og anvendelser deraf | |
| DK1736541T3 (da) | Nyt modificeret galectin 9-protein og anvendelse heraf | |
| DE60336880D1 (de) | Vorrichtungen zur Dekodierung von bewegten Bildern | |
| IS8277A (is) | Blanda af serótónín endurupptöku hindra og glysínflutningsprótín gerð I hindra við meðferð á þunglyndi | |
| NO20055708D0 (no) | Syntetisk gen som koder for humant karsinembryonalt antigen og anvendelser derav | |
| IS8308A (is) | Amínósýrur með sækni fyrir a2o prótíninu | |
| IS8489A (is) | Umritunarstillar og aðferðir þeirra | |
| EP1734983A4 (en) | MODIFIED ANNEXINE PROTEINS AND METHODS FOR PREVENTING THROMBOSIS | |
| IS7962A (is) | Þíenópýridasínón og notkun þeirra í breytingu á sjálfsnæmissjúkdómi | |
| IS8326A (is) | Blandan af serótónín endurupptöku hindra og loxapíni | |
| FI20040655L (fi) | Proteiini- ja peptidistabilointi | |
| NO20055668D0 (no) | Beta-amyloidinhibitorer og anvendelse derav | |
| FI20030315A0 (fi) | Menetelmiä ja konstruktioita valikoitujen aminohappojen pitoisuuksien lisäämiseksi siemenissä | |
| NO20024029D0 (no) | Nytt protein og gen som koder for proteinet | |
| ES1052162Y (es) | Contenedor para ostricultura y similares. |